Aug 2026
KS79356, a novel kynureninase inhibitor, suppresses triple-negative breast cancer progression by attenuating the TNF-α/NFκB–CD44–Akt signaling axis
Maha Alamodi Alghamdi, Hemali Deshpande, Ashish Kumar et al.
· Medical Oncology · 0 citations